Tag: metabolicSyndrome

Articles

• Influence of BMI, metabolic syndrome and diabetes on TN prognosis
• Triple negative breast cancer characteristics

News

11/09/14

Metformin inhibits metastasis of triple negative breast cancer cells

01/01/11

High waist to hip ratio more strongly associated with risk of ER- BC

Studies

• The association of metabolic syndrome scores trajectory patterns with risk of all cancer types Cite
  Deng L, Liu T, Liu C, Zhang Q, Song M, Lin S, et al. The association of metabolic syndrome scores trajectory patterns with risk of all cancer types. Cancer. Wiley; 2024; 10.1002/cncr.35235
• Metabolic Syndrome and the Risk of Ductal Carcinoma In Situ of the Breast in the UK Biobank Cite
  Peila R, Rohan TE. Metabolic Syndrome and the Risk of Ductal Carcinoma In Situ of the Breast in the UK Biobank. Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research (AACR); 2024; 33:333-336 10.1158/1055-9965.epi-23-0846
• Association between insulin resistance and cardiac remodeling in HER2-positive breast cancer patients: a real-world study Cite
  Shi Y, Qiu Z, Yu J, Li Z, Hua S, Chen Y, et al. Association between insulin resistance and cardiac remodeling in HER2-positive breast cancer patients: a real-world study. BMC Cancer. Springer Science and Business Media LLC; 2023; 23 10.1186/s12885-023-11102-y
• Insulin resistance in patients with cancer: a systematic review and meta-analysis Cite
  Màrmol JM, Carlsson M, Raun SH, Grand MK, Sørensen J, Lang Lehrskov L, et al. Insulin resistance in patients with cancer: a systematic review and meta-analysis. Acta Oncologica. Informa UK Limited; 2023; 62:364-371 10.1080/0284186x.2023.2197124
• Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition Cite
  Mahamat‐Saleh Y, Rinaldi S, Kaaks R, Biessy C, Gonzalez‐Gil EM, Murphy N, et al. Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition. Cancer Medicine. Wiley; 2023; 10.1002/cam4.5896
• Cholesterol and breast cancer risk: a cohort study using health insurance claims and health checkup databases Cite
  Narii N, Zha L, Komatsu M, Kitamura T, Sobue T, Ogawa T. Cholesterol and breast cancer risk: a cohort study using health insurance claims and health checkup databases. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-06917-z
• J-shaped association between uric acid and breast cancer risk: a prospective case–control study Cite
  Fan K, Sun T, Yin F. J-shaped association between uric acid and breast cancer risk: a prospective case–control study. Journal of Cancer Research and Clinical Oncology. Springer Science and Business Media LLC; 2023; 10.1007/s00432-023-04725-y
• Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study Cite
  Scott OW, TinTin S, Harborg S, Kuper-Hommel MJJ, Lawrenson R, Elwood JM. Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-022-06815-w
• DNA methylation in peripheral blood leukocytes for the association with glucose metabolism and invasive breast cancer Cite
  Jung SY, Bhatti P, Pellegrini M. DNA methylation in peripheral blood leukocytes for the association with glucose metabolism and invasive breast cancer. Clinical Epigenetics. Springer Science and Business Media LLC; 2023; 15 10.1186/s13148-023-01435-7
• Role of Serum Lipids, Blood Glucose and Blood Pressure in Breast Cancer Risk for Women with Type 2 Diabetes Mellitus Cite
  Zhang F, de Bock GH, Denig P, Landman GW, Zhang Q, Sidorenkov G. Role of Serum Lipids, Blood Glucose and Blood Pressure in Breast Cancer Risk for Women with Type 2 Diabetes Mellitus. Clinical Epidemiology. Informa UK Limited; 2023; Volume 15:109-121 10.2147/clep.s386471
• Obesity and metabolic syndrome are associated with short-term endocrine therapy resistance in early ER + breast cancer Cite
  Bergman R, Berko YA, Sanchez V, Sanders ME, Gonzalez-Ericsson PI, Arteaga CL, et al. Obesity and metabolic syndrome are associated with short-term endocrine therapy resistance in early ER + breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-022-06794-y
• Plant-Based and Ketogenic Diets As Diverging Paths to Address Cancer Cite
  Shah UA, Iyengar NM. Plant-Based and Ketogenic Diets As Diverging Paths to Address Cancer. JAMA Oncology. American Medical Association (AMA); 2022; 10.1001/jamaoncol.2022.1769
• Association of Hypertension and Breast Cancer: Antihypertensive Drugs as an Effective Adjunctive in Breast Cancer Therapy Cite
  Fan Y, Khan NH, Farhan Ali Khan M, Ahammad MF, Zulfiqar T, Virk R, et al. Association of Hypertension and Breast Cancer: Antihypertensive Drugs as an Effective Adjunctive in Breast Cancer Therapy. Cancer Management and Research. Informa UK Limited; 2022; Volume 14:1323-1329 10.2147/cmar.s350854
• Metabolic syndrome and breast cancer survivors: a follow-up analysis after completion of chemotherapy Cite
  Dieli-Conwright CM, Wong L, Waliany S, Mortimer JE. Metabolic syndrome and breast cancer survivors: a follow-up analysis after completion of chemotherapy. Diabetology & Metabolic Syndrome. Springer Science and Business Media LLC; 2022; 14 10.1186/s13098-022-00807-y
• Attenuation of obesity-induced hyperlipidemia reduces tumor growth Cite
  Hussain A, Lian J, Watts R, Gutiérrez T, Nelson R, Goping IS, et al. Attenuation of obesity-induced hyperlipidemia reduces tumor growth. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. Elsevier BV; 2022; 1867:159124 10.1016/j.bbalip.2022.159124
• A Systematic Review: Does Insulin Resistance Affect the Risk and Survival Outcome of Breast Cancer in Women? Cite
  Srinivasan M, Arzoun H, GK LB, Thangaraj SR. A Systematic Review: Does Insulin Resistance Affect the Risk and Survival Outcome of Breast Cancer in Women?. Cureus. Cureus, Inc.; 2022; 10.7759/cureus.21712
• Insulin resistance and the development of breast cancer in premenopausal women: the Kangbuk Samsung Health Study Cite
  Lee J, Chang Y, Kim Y, Park B, Ryu S. Insulin resistance and the development of breast cancer in premenopausal women: the Kangbuk Samsung Health Study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-022-06513-7
• A Low-Glucose Eating Pattern Improves Biomarkers of Postmenopausal Breast Cancer Risk: An Exploratory Secondary Analysis of a Randomized Feasibility Trial Cite
  Schembre SM, Jospe MR, Giles ED, Sears DD, Liao Y, Basen-Engquist KM, et al. A Low-Glucose Eating Pattern Improves Biomarkers of Postmenopausal Breast Cancer Risk: An Exploratory Secondary Analysis of a Randomized Feasibility Trial. Nutrients. MDPI AG; 2021; 13:4508 10.3390/nu13124508
• Adipocyte-derived exosomes may promote breast cancer progression in type 2 diabetes Cite
  Jafari N, Kolla M, Meshulam T, Shafran JS, Qiu Y, Casey AN, et al. Adipocyte-derived exosomes may promote breast cancer progression in type 2 diabetes. Science Signaling. American Association for the Advancement of Science (AAAS); 2021; 14 10.1126/scisignal.abj2807
• Circulating lipids and breast cancer prognosis in the Malmö diet and cancer study Cite
  Harborg S, Ahern TP, Feldt M, Rosendahl AH, Cronin-Fenton D, Melander O, et al. Circulating lipids and breast cancer prognosis in the Malmö diet and cancer study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06462-7
• Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: analysis of the MEND study Cite
  Akinyemiju T, Oyekunle T, Salako O, Gupta A, Alatise O, Ogun G, et al. Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: analysis of the MEND study. Clinical Breast Cancer. Elsevier BV; 2021; 10.1016/j.clbc.2021.11.004
• Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells Cite
  Vella V, Giuliano M, La Ferlita A, Pellegrino M, Gaudenzi G, Alaimo S, et al. Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells. Cells. MDPI AG; 2021; 10:3145 10.3390/cells10113145
• High density lipoproteins and oxidative stress in breast cancer Cite
  Mazzuferi G, Bacchetti T, Islam MO, Ferretti G. High density lipoproteins and oxidative stress in breast cancer. Lipids in Health and Disease. Springer Science and Business Media LLC; 2021; 20 10.1186/s12944-021-01562-1
• Investigation of the interplay between circulating lipids and IGF-I and relevance to breast cancer risk: an observational and Mendelian randomization study Cite
  Tan VY, Bull CJ, Biernacka KM, Teumer A, Richardson TG, Sanderson E, et al. Investigation of the interplay between circulating lipids and IGF-I and relevance to breast cancer risk: an observational and Mendelian randomization study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021;:cebp.0315.2021 10.1158/1055-9965.epi-21-0315
• Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women Cite
  Motoki AH, Buttros DA, Gaspar AL, Almeida-Filho BS, Carvalho-Pessoa E, Vespoli HD, et al. Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women. Clinical Breast Cancer. Elsevier BV; 2021; 10.1016/j.clbc.2021.07.009
• Cholesterol lowering drug use and breast cancer survival: the Multiethnic Cohort Study Cite
  Moksud N, Loo LWM, Yang J, Huang C, Haiman CA, Le Marchand L, et al. Cholesterol lowering drug use and breast cancer survival: the Multiethnic Cohort Study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06360-y
• Biomarkers of mammographic density in premenopausal women Cite
  His M, Lajous M, Gómez-Flores-Ramos L, Monge A, Dossus L, Viallon V, et al. Biomarkers of mammographic density in premenopausal women. Breast Cancer Research. Springer Science and Business Media LLC; 2021; 23 10.1186/s13058-021-01454-3
• Multimorbidity clusters among long‐term breast cancer survivors in Spain: Results of the SURBCAN study Cite
  Jansana A, Poblador‐Plou B, Gimeno‐Miguel A, Lanzuela M, Prados‐Torres A, Domingo L, et al. Multimorbidity clusters among long‐term breast cancer survivors in Spain: Results of the SURBCAN study. International Journal of Cancer. Wiley; 2021; 10.1002/ijc.33736
• Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors Cite
  Xu S, Chaudhary O, Rodríguez-Morales P, Sun X, Chen D, Zappasodi R, et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity. Elsevier BV; 2021; 10.1016/j.immuni.2021.05.003
• The Cholesterol Metabolite 27HC Increases Secretion of Extracellular Vesicles Which Promote Breast Cancer Progression Cite
  Baek AE, Krawczynska N, Das Gupta A, Dvoretskiy SV, You S, Park J, et al. The Cholesterol Metabolite 27HC Increases Secretion of Extracellular Vesicles Which Promote Breast Cancer Progression. Endocrinology. The Endocrine Society; 2021; 162 10.1210/endocr/bqab095
• The Hypertension Related Gene G-Protein Coupled Receptor Kinase 4 Contributes to Breast Cancer Proliferation Cite
  Yue W, Tran HT, Wang J, Schiermeyer K, Gildea JJ, Xu P, et al. The Hypertension Related Gene G-Protein Coupled Receptor Kinase 4 Contributes to Breast Cancer Proliferation. Breast Cancer: Basic and Clinical Research. SAGE Publications; 2021; 15:117822342110157 10.1177/11782234211015753
• Beta-blockers use and risk of breast cancer in women with hypertension Cite
  Zheng G, Sundquist J, Sundquist K, Ji J. Beta-blockers use and risk of breast cancer in women with hypertension. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021;:cebp.1599.2020 10.1158/1055-9965.epi-20-1599
• Metabolic syndrome risk components and mortality after triple‐negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative Cite
  Yuan Y, Pan K, Mortimer J, Chlebowski RT, Luo J, Yan JE, et al. Metabolic syndrome risk components and mortality after triple‐negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative. Cancer. Wiley; 2021; 10.1002/cncr.33407
• Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population? Cite
  Kennard K, Buckley ME, Sizer LM, Larson S, Carter WB, Frazier TG, et al. Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population?. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-020-06034-1
• The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study Cite
  Johnson KE, Siewert KM, Klarin D, Damrauer SM, Chang K, Tsao PS, et al. The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study. PLOS Medicine. Public Library of Science (PLoS); 2020; 17:e1003302 10.1371/journal.pmed.1003302
• Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment? Cite
  Alan O, Akin Telli T, Aktas B, Koca S, Ökten IN, Hasanov R, et al. Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?. World Journal of Surgical Oncology. Springer Science and Business Media LLC; 2020; 18 10.1186/s12957-020-02019-y
• Influence of Metabolic Syndrome on Risk of Breast Cancer: A Study Analyzing Nationwide Data from Korean National Health Insurance Service Cite
  Hwang K, Han K, Oh S, Koo BK, Lee SK, Kim J, et al. Influence of Metabolic Syndrome on Risk of Breast Cancer: A Study Analyzing Nationwide Data from Korean National Health Insurance Service. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2020; 29:2038-2047 10.1158/1055-9965.epi-20-0300
• Cholesterol as an Endogenous Ligand of ERRα Promotes ERRα-Mediated Cellular Proliferation and Metabolic Target Gene Expression in Breast Cancer Cells Cite
  Ghanbari F, Mader S, Philip A. Cholesterol as an Endogenous Ligand of ERRα Promotes ERRα-Mediated Cellular Proliferation and Metabolic Target Gene Expression in Breast Cancer Cells. Cells. MDPI AG; 2020; 9:1765 10.3390/cells9081765
• Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women’s Health Initiative Cite
  Pan K, Chlebowski RT, Mortimer JE, Gunther MJ, Rohan T, Vitolins MZ, et al. Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women’s Health Initiative. Cancer. Wiley; 2020; 126:3638-3647 10.1002/cncr.33002
• Abstract C122: Ethnicity as a moderator of the effects of aerobic and resistance exercise on metabolic syndrome in breast cancer survivors Cite
  Dieli-Conwright CM, Sweeney FC, Courneya KS, Tripathy D, Sami N, Lee K, et al. Abstract C122: Ethnicity as a moderator of the effects of aerobic and resistance exercise on metabolic syndrome in breast cancer survivors. Poster Presentations - Proffered Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7755.disp18-c122
• Endocytosis of very low-density lipoproteins: an unexpected mechanism for lipid acquisition by breast cancer cells Cite
  Lupien LE, Bloch K, Dehairs J, Traphagen NA, Feng WW, Davis WL, et al. Endocytosis of very low-density lipoproteins: an unexpected mechanism for lipid acquisition by breast cancer cells. Journal of Lipid Research. American Society for Biochemistry & Molecular Biology (ASBMB); 2019; 61:205-218 10.1194/jlr.ra119000327
• Air pollution, noise exposure, and metabolic syndrome – A cohort study in elderly Mexican-Americans in Sacramento area Cite
  Yu Y, Paul K, Arah OA, Mayeda ER, Wu J, Lee E, et al. Air pollution, noise exposure, and metabolic syndrome – A cohort study in elderly Mexican-Americans in Sacramento area. Environment International. Elsevier BV; 2020; 134:105269 10.1016/j.envint.2019.105269
• Association Between Metabolic Syndrome and Breast Cancer Risk: An Updated Meta-Analysis of Follow-Up Studies Cite
  Guo M, Liu T, Li P, Wang T, Zeng C, Yang M, et al. Association Between Metabolic Syndrome and Breast Cancer Risk: An Updated Meta-Analysis of Follow-Up Studies. Frontiers in Oncology. Frontiers Media SA; 2019; 9 10.3389/fonc.2019.01290
• Linoleic acid induces an increased response to insulin in MDA‐MB‐231 breast cancer cells Cite
  Rodriguez‐Monterrosas C, Diaz‐Aragon R, Cortes‐Reynosa P, Salazar EP. Linoleic acid induces an increased response to insulin in MDA‐MB‐231 breast cancer cells. Journal of Cellular Biochemistry. Wiley; 2018; 119:5413-5425 10.1002/jcb.26694
• Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative Cite
  Simon MS, Beebe-Dimmer JL, Hastert TA, Manson JE, Cespedes Feliciano EM, Neuhouser ML, et al. Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative. Cancer. Wiley; 2018; 124:1798-1807 10.1002/cncr.31230
• Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women Cite
  Kabat GC, Kim MY, Lee JS, Ho GY, Going SB, Beebe-Dimmer J, et al. Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2017; 26:1730-1735 10.1158/1055-9965.epi-17-0495
• Metabolic conditions and breast cancer risk among Los Angeles County Filipina Americans compared with Chinese and Japanese Americans Cite
  Wu AH, Vigen C, Butler LM, Tseng C. Metabolic conditions and breast cancer risk among Los Angeles County Filipina Americans compared with Chinese and Japanese Americans. International Journal of Cancer. Wiley; 2017; 141:2450-2461 10.1002/ijc.31018
• Adherence to Mediterranean Diet and Metabolic Syndrome in BRCA Mutation Carriers Cite
  Bruno E, Manoukian S, Venturelli E, Oliverio A, Rovera F, Iula G, et al. Adherence to Mediterranean Diet and Metabolic Syndrome in BRCA Mutation Carriers. Integrative Cancer Therapies. SAGE Publications; 2017; 17:153-160 10.1177/1534735417721015
• Metabolic factors, anthropometric measures, diet, and physical activity in long-term breast cancer survivors: change from diagnosis and comparison to non-breast cancer controls Cite
  Lohmann AE, Ennis M, Taylor SK, Goodwin PJ. Metabolic factors, anthropometric measures, diet, and physical activity in long-term breast cancer survivors: change from diagnosis and comparison to non-breast cancer controls. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 164:451-460 10.1007/s10549-017-4263-z
• Chlorogenic Acid: Recent Advances on Its Dual Role as a Food Additive and a Nutraceutical against Metabolic Syndrome Cite
  Santana-Gálvez J, Cisneros-Zevallos L, Jacobo-Velázquez D. Chlorogenic Acid: Recent Advances on Its Dual Role as a Food Additive and a Nutraceutical against Metabolic Syndrome. Molecules. MDPI AG; 2017; 22:358 10.3390/molecules22030358
• Metabolic syndrome and incidence of breast cancer in middle-aged Korean women: a nationwide cohort study Cite
  Lee JA, Yoo JE, Park HS. Metabolic syndrome and incidence of breast cancer in middle-aged Korean women: a nationwide cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 162:389-393 10.1007/s10549-017-4131-x
• Metabolic syndrome in breast cancer survivors with high carbohydrate consumption: The first report in community setting Cite
  Park B, Kong S, Lee EK, Lee MH, Lee ES. Metabolic syndrome in breast cancer survivors with high carbohydrate consumption: The first report in community setting. Clinical Nutrition. Elsevier BV; 2017; 36:1372-1377 10.1016/j.clnu.2016.09.006
• Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression Cite
  Ferroni P, Riondino S, Laudisi A, Portarena I, Formica V, Alessandroni J, et al. Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression. The Oncologist. Wiley; 2016; 21:1041-1049 10.1634/theoncologist.2015-0462
• Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis Cite
  Guenancia C, Lefebvre A, Cardinale D, Yu AF, Ladoire S, Ghiringhelli F, et al. Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:3157-3165 10.1200/jco.2016.67.4846
• An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy Cite
  Dieli‐Conwright CM, Wong L, Waliany S, Bernstein L, Salehian B, Mortimer JE. An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy. Cancer. Wiley; 2016; 122:2646-2653 10.1002/cncr.30104
• High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells Cite
  Flores-López LA, Martínez-Hernández MG, Viedma-Rodríguez R, Díaz-Flores M, Baiza-Gutman LA. High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells. Cellular Oncology. Springer Science and Business Media LLC; 2016; 39:365-378 10.1007/s13402-016-0282-8
• Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study Cite
  Agresti R, Meneghini E, Baili P, Minicozzi P, Turco A, Cavallo I, et al. Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 157:179-189 10.1007/s10549-016-3802-3
• Abstract A74: Metabolic syndrome in Latina breast cancer survivors after adjuvant chemotherapy Cite
  Dieli-Conwright CM, Mortimer JE, Spicer D, Tripathy D. Abstract A74: Metabolic syndrome in Latina breast cancer survivors after adjuvant chemotherapy. Epidemiology, Lifestyle, and Genetics. American Association for Cancer Research; 2016; 10.1158/1538-7755.disp15-a74
• Abstract C65: Defining the implications of sugar derived metabolites (AGEs) to tamoxifen resistance and breast cancer disparity: Is it a question of lifestyle? Cite
  Walter KR, Smith DM, Phan V, spruill L, Ford ME, Findlay VJ, et al. Abstract C65: Defining the implications of sugar derived metabolites (AGEs) to tamoxifen resistance and breast cancer disparity: Is it a question of lifestyle?. Organ Site Research. American Association for Cancer Research; 2016; 10.1158/1538-7755.disp15-c65
• Abstract P4-10-05: Changes in metabolic syndrome components in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy Cite
  Dieli-Conwright C, Wong L, Waliany S, Bernstein L, Salehian B, Mortimer J. Abstract P4-10-05: Changes in metabolic syndrome components in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy. Poster Session Abstracts. American Association for Cancer Research; 2016; 10.1158/1538-7445.sabcs15-p4-10-05
• Associations between Metabolic Syndrome and Three-dimensional Breast Density Using Digital Mammography Cite
  Bhang S, Lee H, Kang J, Yu B. Associations between Metabolic Syndrome and Three-dimensional Breast Density Using Digital Mammography. Korean Journal of Health Promotion. Korean Society of Health Promotion and Disease Prevention (KAMJE); 2015; 15:168 10.15384/kjhp.2015.15.4.168
• Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer Cite
  Iyengar NM, Zhou XK, Gucalp A, Morris PG, Howe LR, Giri DD, et al. Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer. Clinical Cancer Research. American Association for Cancer Research (AACR); 2015; 22:2283-2289 10.1158/1078-0432.ccr-15-2239
• Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis Cite
  Wulaningsih W, Vahdaninia M, Rowley M, Holmberg L, Garmo H, Malmstrom H, et al. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis. BMC Cancer. Springer Science and Business Media LLC; 2015; 15 10.1186/s12885-015-1928-z
• Metabolic syndrome and breast cancer prognosis Cite
  Berrino F, Villarini A, Traina A, Bonanni B, Panico S, Mano MP, et al. Metabolic syndrome and breast cancer prognosis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2014; 147:159-165 10.1007/s10549-014-3076-6
• Modification of Abdominal Fat Distribution After Aromatase Inhibitor Therapy in Breast Cancer Patients Visualized Using 3-D Computed Tomography Volumetry Cite
  Battisti S, Guida FM, Coppa F, Vaccaro DM, Santini D, Tonini G, et al. Modification of Abdominal Fat Distribution After Aromatase Inhibitor Therapy in Breast Cancer Patients Visualized Using 3-D Computed Tomography Volumetry. Clinical Breast Cancer. Elsevier BV; 2014; 14:365-370 10.1016/j.clbc.2014.02.003
• High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease Cite
  Minicozzi P, Berrino F, Sebastiani F, Falcini F, Vattiato R, Cioccoloni F, et al. High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease. European Journal of Cancer. Elsevier BV; 2013; 49:3881-3888 10.1016/j.ejca.2013.08.004
• Total Serum Cholesterol and Cancer Incidence in the Metabolic Syndrome and Cancer Project (Me-Can) Cite
  Strohmaier S, Edlinger M, Manjer J, Stocks T, Bjørge T, Borena W, et al. Total Serum Cholesterol and Cancer Incidence in the Metabolic Syndrome and Cancer Project (Me-Can). PLoS ONE. Public Library of Science (PLoS); 2013; 8:e54242 10.1371/journal.pone.0054242
• Effects of ALA, EPA and DHA in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats Cite
  Poudyal H, Panchal SK, Ward LC, Brown L. Effects of ALA, EPA and DHA in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. The Journal of Nutritional Biochemistry. Elsevier BV; 2013; 24:1041-1052 10.1016/j.jnutbio.2012.07.014
• A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy Cite
  Stebbing J, Sharma A, North B, Athersuch T, Zebrowski A, Pchejetski D, et al. A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy. Annals of Oncology. Elsevier BV; 2012; 23:860-866 10.1093/annonc/mdr347
• Survival effects of prenatal famine exposure Cite
  van Abeelen AF, Veenendaal MV, Painter RC, de Rooij SR, Dijkgraaf MG, Bossuyt PM, et al. Survival effects of prenatal famine exposure. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2011; 95:179-183 10.3945/ajcn.111.022038
• Role of Cholesterol in the Development and Progression of Breast Cancer Cite
  Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, et al. Role of Cholesterol in the Development and Progression of Breast Cancer. The American Journal of Pathology. Elsevier BV; 2011; 178:402-412 10.1016/j.ajpath.2010.11.005
• Fasting C-Peptide Levels and Death Resulting From All Causes and Breast Cancer: The Health, Eating, Activity, and Lifestyle Study Cite
  Irwin ML, Duggan C, Wang C, Smith AW, McTiernan A, Baumgartner RN, et al. Fasting C-Peptide Levels and Death Resulting From All Causes and Breast Cancer: The Health, Eating, Activity, and Lifestyle Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:47-53 10.1200/jco.2010.28.4752
• Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy Cite
  Phoenix KN, Vumbaca F, Fox MM, Evans R, Claffey KP. Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2009; 123:333-344 10.1007/s10549-009-0647-z
• Metabolic Syndrome and Breast Cancer in the Me-Can (Metabolic Syndrome and Cancer) Project Cite
  Bjørge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, et al. Metabolic Syndrome and Breast Cancer in the Me-Can (Metabolic Syndrome and Cancer) Project. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2010; 19:1737-1745 10.1158/1055-9965.epi-10-0230
• Abstract 72: Metformin enhances tumor regression and reduces tumor burden in a preclinical paradigm modeling obesity's impact on postmenopausal breast cancer Cite
  Giles ED, Anderson SM, Schedin PJ, Thor AD, Johnson GC, Hedman KJ, et al. Abstract 72: Metformin enhances tumor regression and reduces tumor burden in a preclinical paradigm modeling obesity's impact on postmenopausal breast cancer. Cellular and Molecular Biology. American Association for Cancer Research; 2010; 10.1158/1538-7445.am10-72
• The association of metabolic syndrome with triple-negative breast cancer Cite
  Maiti B, Kundranda MN, Spiro TP, Daw HA. The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2009; 121:479-483 10.1007/s10549-009-0591-y
• A Longitudinal Study of the Metabolic Syndrome and Risk of Postmenopausal Breast Cancer Cite
  Kabat GC, Kim M, Chlebowski RT, Khandekar J, Ko MG, McTiernan A, et al. A Longitudinal Study of the Metabolic Syndrome and Risk of Postmenopausal Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2009; 18:2046-2053 10.1158/1055-9965.epi-09-0235
• The effects of high walnut and cashew nut diets on the antioxidant status of subjects with metabolic syndrome Cite
  Davis L, Stonehouse W, Loots DT, Mukuddem-Petersen J, van der Westhuizen FH, Hanekom SM, et al. The effects of high walnut and cashew nut diets on the antioxidant status of subjects with metabolic syndrome. European Journal of Nutrition. Springer Science and Business Media LLC; 2007; 46:155-164 10.1007/s00394-007-0647-x